Doody Kevin 4
4 · INVO Bioscience, Inc. · Filed Jan 18, 2022
Insider Transaction Report
Form 4
Doody Kevin
DirectorMedical Director
Transactions
- Award
Common Stock
2022-01-15+7,480→ 177,306 total - Award
Stock Option
2022-01-15+9,088→ 9,088 totalExercise: $3.61Exp: 2032-01-14→ Common Stock (9,088 underlying)
Footnotes (1)
- [F1]The stock option vests in monthly increments over a period of twelve months from the date of grant.